drugset / Trial / NCT01288391
Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial is conducted in Europe and Japan. The aim of this trial is to assess the safety and pharmacokinetics (the rate at which the body eliminates the trial drug) of single doses of NNC128-0000-2011, when administered i.v. (intravenously) to haemophilia patients.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NNC 0128-0000-2011 | Unknown | 100 ug/kg | Intravenous |
| Subject | NNC 0128-0000-2011 | Unknown | 200 ug/kg | Intravenous |